Listed

Sanofi

An insider at 4 companies in coverage, as reported on Form 4. SEC CIK 1121404. Latest Form 4 filed Feb 18, 2016.

Share

Roles

As stated on the filings: the relationship to the company and any officer title.

Sanofi, roles by company
CompanyRoleTransactionsFirstLatest
Latigo Biotherapeutics, Inc.LTGO10% owner42026-08-102026-08-10
Regeneron Pharmaceuticals, Inc.REGN10% owner5512010-10-132020-06-09
Fulcrum Therapeutics, Inc.FULC10% owner32019-07-222019-07-22
Alnylam Pharmaceuticals, Inc.ALNY10% owner62015-01-222017-05-31

Transactions: 564

Every transaction reported, newest first, including grants, exercises and derivative securities. Purchases and sales (codes P and S) are open-market trades. The reported price is as stated on the form.

What these mean: insiders, Form 4, transaction codes, Rule 10b5-1 plans.

Sanofi, transactions
DateCompanyTransactionSharesReported priceValueFiling
2016-02-16Regeneron Pharmaceuticals, Inc.10% owner Purchase2,145$387.4283$831.0kForm 4
2016-02-01Alnylam Pharmaceuticals, Inc.10% owner Purchase205,030$69.75$14.3mForm 4
2016-01-12Regeneron Pharmaceuticals, Inc.10% owner Purchase3,563$472.641$1.7mForm 4
2016-01-12Regeneron Pharmaceuticals, Inc.10% owner Purchase3,600$471.5617$1.7mForm 4
2016-01-12Regeneron Pharmaceuticals, Inc.10% owner Purchase7,204$470.6444$3.4mForm 4
2016-01-12Regeneron Pharmaceuticals, Inc.10% owner Purchase14,169$469.7058$6.7mForm 4
2016-01-12Regeneron Pharmaceuticals, Inc.10% owner Purchase5,082$468.4646$2.4mForm 4
2016-01-12Regeneron Pharmaceuticals, Inc.10% owner Purchase4,901$467.6617$2.3mForm 4
2016-01-12Regeneron Pharmaceuticals, Inc.10% owner Purchase3,608$466.2618$1.7mForm 4
2016-01-12Regeneron Pharmaceuticals, Inc.10% owner Purchase8,002$465.4998$3.7mForm 4
2016-01-12Regeneron Pharmaceuticals, Inc.10% owner Purchase4,148$464.411$1.9mForm 4
2016-01-12Regeneron Pharmaceuticals, Inc.10% owner Purchase2,759$463.1723$1.3mForm 4
2016-01-12Regeneron Pharmaceuticals, Inc.10% owner Purchase4,941$462.2263$2.3mForm 4
2016-01-12Regeneron Pharmaceuticals, Inc.10% owner Purchase3,563$461.4128$1.6mForm 4
2016-01-12Regeneron Pharmaceuticals, Inc.10% owner Purchase2,500$460.1156$1.2mForm 4
2016-01-12Regeneron Pharmaceuticals, Inc.10% owner Purchase3,100$457.9952$1.4mForm 4
2016-01-12Regeneron Pharmaceuticals, Inc.10% owner Purchase3,220$457.1844$1.5mForm 4
2016-01-12Regeneron Pharmaceuticals, Inc.10% owner Purchase2,164$455.6774$986.1kForm 4
2016-01-12Regeneron Pharmaceuticals, Inc.10% owner Purchase2,407$454.5971$1.1mForm 4
2016-01-12Regeneron Pharmaceuticals, Inc.10% owner Purchase5,007$453.8912$2.3mForm 4
2015-10-06Regeneron Pharmaceuticals, Inc.10% owner Purchase2,300$469.461$1.1mForm 4
2015-10-06Regeneron Pharmaceuticals, Inc.10% owner Purchase1,702$468.4879$797.4kForm 4
2015-10-06Regeneron Pharmaceuticals, Inc.10% owner Purchase2,200$467.3464$1.0mForm 4
2015-10-06Regeneron Pharmaceuticals, Inc.10% owner Purchase900$466.0381$419.4kForm 4
2015-10-06Regeneron Pharmaceuticals, Inc.10% owner Purchase1,190$464.5745$552.8kForm 4
2015-10-06Regeneron Pharmaceuticals, Inc.10% owner Purchase5,812$463.7103$2.7mForm 4
2015-10-06Regeneron Pharmaceuticals, Inc.10% owner Purchase5,411$462.6074$2.5mForm 4
2015-10-06Regeneron Pharmaceuticals, Inc.10% owner Purchase9,271$461.6131$4.3mForm 4
2015-10-06Regeneron Pharmaceuticals, Inc.10% owner Purchase12,798$460.7054$5.9mForm 4
2015-10-06Regeneron Pharmaceuticals, Inc.10% owner Purchase6,697$459.5495$3.1mForm 4
2015-10-06Regeneron Pharmaceuticals, Inc.10% owner Purchase9,730$458.5797$4.5mForm 4
2015-10-06Regeneron Pharmaceuticals, Inc.10% owner Purchase2,938$457.6022$1.3mForm 4
2015-10-06Regeneron Pharmaceuticals, Inc.10% owner Purchase2,480$456.5556$1.1mForm 4
2015-10-06Regeneron Pharmaceuticals, Inc.10% owner Purchase3,601$455.558$1.6mForm 4
2015-10-06Regeneron Pharmaceuticals, Inc.10% owner Purchase4,140$454.4757$1.9mForm 4
2015-10-06Regeneron Pharmaceuticals, Inc.10% owner Purchase3,842$453.4794$1.7mForm 4
2015-10-06Regeneron Pharmaceuticals, Inc.10% owner Purchase1,768$452.3727$799.8kForm 4
2015-10-06Regeneron Pharmaceuticals, Inc.10% owner Purchase1,451$451.3084$654.8kForm 4
2015-10-06Regeneron Pharmaceuticals, Inc.10% owner Purchase1,200$450.2306$540.3kForm 4
2015-10-06Regeneron Pharmaceuticals, Inc.10% owner Purchase1,107$449.1383$497.2kForm 4
2015-10-06Regeneron Pharmaceuticals, Inc.10% owner Purchase100$476.85$47.7kForm 4
2015-10-06Regeneron Pharmaceuticals, Inc.10% owner Purchase700$476.3543$333.4kForm 4
2015-10-06Regeneron Pharmaceuticals, Inc.10% owner Purchase1,000$474.265$474.3kForm 4
2015-10-06Regeneron Pharmaceuticals, Inc.10% owner Purchase1,000$473.3125$473.3kForm 4
2015-10-06Regeneron Pharmaceuticals, Inc.10% owner Purchase2,650$472.3657$1.3mForm 4
2015-10-06Regeneron Pharmaceuticals, Inc.10% owner Purchase3,625$471.6367$1.7mForm 4
2015-10-06Regeneron Pharmaceuticals, Inc.10% owner Purchase1,965$470.4102$924.4kForm 4
2015-09-23Regeneron Pharmaceuticals, Inc.10% owner Purchase3,729$539.9825$2.0mForm 4
2015-09-23Regeneron Pharmaceuticals, Inc.10% owner Purchase11,212$539.1918$6.0mForm 4
2015-09-23Regeneron Pharmaceuticals, Inc.10% owner Purchase15,274$538.3122$8.2mForm 4

Source: SEC EDGAR, Forms 4. Last ingested by Listed: Nov 1, 2026, 01:12 ET. Listed shows no prices and gives no investment advice.